DNA
Gene silencing: A potential new treatment for rare disease
June 28 by Giles CampionWe look at the latest development in precision medicine: gene silencing
How phenotyping could transform the way obesity is treated
June 23 by Leila HawkinsPharma IQ speaks to Phenomix about using genetics to better understand the causes of obesity
Rewriting the human genome
March 15 by Pharma IQFind out how the CRISPR market is developing and why it's influential to the world as we know it.
250,000 DNA samples and 2.8m patient records to power medical industry
April 16 by Chanice HenryTo fast-track the development of innovative medicines, a biotech start-up is opening access to its extensive genomic and bioinformatics resources.
CRISPR Cas9 Troubleshooting Analysis
October 12 by Pharmaceuticals & Biotechnology EditorThe CRISPR Cas9 tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing. The cutting edge method is being used to revolutionize re...
Fit for Purpose
September 22 by Tony HitchcockAt Cobra we have worked on the development of both naked plasmid DNA and viral gene therapy products for over 20 years. After some rather extended development times, it has been very rewarding to se...
CRISPR CAS9 Emerging Technologies
September 14 by Pharma IQ NewsThe trailblazing CRISPR Cas9 technique has vastly widened the gene editing horizons for the R&D industry. The technique has been gaining popularity since its inception in 2013, with some job adver...
Project Snapshot: CRISPR Cas9
August 28 by Pharmaceuticals & Biotechnology EditorPharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project. [inlinead]...
Introducing The New Molecular Scissors - CRISPR & Cas9
August 02 by Chanice HenryThe CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing.CRISPR alongside the use of the Cas9 protein enables the ability to target a...
CRISPR Industry Insight Survey
July 31 by Pharma IQ SurveysPharma IQ invites you to take part in our short survey, due to feature in our 2015 CRISPR Research Report in preparation for the Gene Editing CRISPR Summit taking place from 7th - 9th December...
US Supreme Court: “Isolated DNA cannot be patented”
June 13 by Pharma IQ News- Comment from Intellectual Property specialists Marks & Clerk on US Supreme Court ruling on patentability of isolated DNA – The US Supreme Court has today dealt a blow to the worldwide...
Why Not Sequence the Whole Genome?
September 13 by Andrea CharlesProfessor René Bernards, Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-ge...